Key facts
- Notable investors include Oak HC/FT.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Artis BioSolutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Artis BioSolutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Artis BioSolutions
Operator of a biopharmaceutical company intended to advance the discovery, development, and production of genetic medicines and biologics. The company offers expertise in nucleic acids, lipid nanoparticles, and mRNA technologies for therapeutic development, supporting clients through early-phase development to commercial readiness, enabling clinicians to accelerate the transition of complex therapeutics from discovery to clinical readiness.
- Sector
- Healthcare
- HQ
- Carlsbad, CA, United States
- Founded
- 2024
- Employees
- 5
- Website
- artisbiosolutions.com/
- Ownership
- Privately Held (backing)
Artis BioSolutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Artis BioSolutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Artis BioSolutions in its N-PORT filings yet. We sweep new filings monthly.